What Is the Medicare Part D Donut Hole (Coverage Gap)?

The Medicare Part D donut hole, also known as the coverage gap, is a temporary limit on what Medicare will cover for prescription drugs. This phase of coverage occurs after a beneficiary and their insurance plan have spent a certain amount on covered drugs but before reaching the threshold for catastrophic coverage, where out-of-pocket costs significantly decrease. Understanding how the donut hole works is essential for Medicare beneficiaries who rely on prescription medications, as it can impact their drug costs during the year.

How the Medicare Part D Donut Hole Works

Medicare Part D provides prescription drug coverage through private insurance plans approved by Medicare. Each year, a beneficiary moves through different phases of coverage based on their total drug spending. The progression follows these stages:

1. Deductible Phase – The beneficiary pays out of pocket until the plan’s annual deductible is met (if the plan has one). Some Medicare Part D plans have a $0 deductible, while others require payment up to the federally set limit.
2. Initial Coverage Phase – After the deductible is met, the plan covers a portion of the drug costs, and the beneficiary pays a copayment or coinsurance. This phase continues until total drug spending (including what the plan and the beneficiary pay) reaches the coverage gap threshold.
3. Coverage Gap (Donut Hole) Phase – Once total drug costs exceed a specific annual limit, the beneficiary enters the coverage gap. During this phase, they are responsible for a higher percentage of the cost of their medications, though discounts help reduce the financial burden.
4. Catastrophic Coverage Phase – If out-of-pocket spending reaches a higher threshold, the beneficiary exits the donut hole and enters catastrophic coverage. At this point, drug costs are greatly reduced, and the beneficiary pays only a small coinsurance or copay for medications for the remainder of the year.

Donut Hole Costs and Discounts

The Affordable Care Act (ACA) gradually reduced the impact of the coverage gap, introducing manufacturer discounts and increased Medicare contributions to lessen out-of-pocket costs. Currently, beneficiaries in the donut hole receive a 75% discount on both brand-name and generic drugs. This means they pay 25% of the cost while receiving credit for almost the full price of brand-name medications toward their out-of-pocket spending requirement.

For example, if a brand-name drug has a retail price of $100, the beneficiary pays $25, but their out-of-pocket spending record reflects around $95, bringing them closer to the catastrophic coverage threshold.

For generic drugs, the process differs slightly. Medicare subsidizes a significant portion of the cost, but beneficiaries still pay 25% of the price, and only their actual out-of-pocket spending counts toward exiting the donut hole.

Reaching Catastrophic Coverage

Beneficiaries exit the donut hole and enter catastrophic coverage once their true out-of-pocket costs (TrOOP) exceed a federally determined amount for the year. TrOOP includes:

• The amount the beneficiary pays during the coverage gap
• The manufacturer discount on brand-name drugs
• Deductible and copayments from the initial coverage phase

However, contributions from the Medicare plan itself do not count toward reaching catastrophic coverage. Once in this final phase, beneficiaries pay a small copay or about 5% of drug costs, depending on the medication, for the rest of the year.

Changes and Future Modifications

The Medicare Part D landscape continues to evolve, particularly with the Inflation Reduction Act of 2022, which aims to further reduce prescription drug costs for seniors. One of the key changes scheduled for 2025 is the elimination of the coverage gap as a separate phase, transitioning toward a simplified out-of-pocket cap for Medicare Part D enrollees. Under the new system, once a beneficiary reaches a designated annual spending limit, they will no longer pay anything for their prescriptions for the remainder of the year.

Who is Affected by the Donut Hole?

Not all Medicare Part D beneficiaries experience the donut hole. The impact depends on an individual’s prescription drug costs. Those with minimal medication needs may never reach the coverage gap, while those requiring high-cost prescriptions may enter the donut hole earlier in the year. People with Medicare Extra Help (Low-Income Subsidy) avoid the donut hole entirely, as their prescription costs are already capped.

Strategies to Manage Costs in the Donut Hole

Beneficiaries who find themselves in the coverage gap can explore several options to help manage expenses:

• Switching to generics or lower-cost alternatives – Consulting with a doctor or pharmacist about generic versions of medications can reduce costs significantly.
• Using manufacturer and state assistance programs – Some pharmaceutical companies offer financial assistance to Medicare recipients.
• Pharmacy discount programs and coupons – Third-party discount cards or manufacturer coupons may offer savings, though they do not count toward TrOOP.
• Mail-order or bulk purchasing – Some Medicare drug plans offer discounts for mail-order prescriptions or bulk purchases.
• Reviewing plan options annually – Each year, Medicare beneficiaries can review and switch plans during open enrollment (October 15 – December 7) to find a plan with better drug coverage or lower out-of-pocket costs.

The Bottom Line

The Medicare Part D donut hole is a temporary coverage gap that affects how much beneficiaries pay for prescriptions. While legislative changes have helped reduce costs, many seniors and disabled individuals still face higher out-of-pocket expenses before reaching catastrophic coverage. Understanding how the coverage gap works, taking advantage of available discounts, and proactively managing prescription costs can help mitigate the financial impact of this phase. With upcoming changes set to eliminate the donut hole in 2025, Medicare drug coverage is moving toward a more predictable and affordable structure for enrollees.